HAEMONETICS CORP — Director's Dealing 2014

Oct 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-10-27

Reporting Person: CONCANNON BRIAN (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-27	Common Stock	D	2188.0	$35.92	Disposed	153049	Direct
2014-10-28	Common Stock	D	2794.0	$36.22	Disposed	150255	Direct
2014-10-28	Common Stock	D	3215.0	$36.22	Disposed	147040	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.